Lundbeck's Rexulti Growth Hopes Clouded By Dementia Agitation Data Setback

MRI
Rexulti Needs Deciding Phase III Trial In Dementia-Related Agitation • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Neurological

More from Therapeutic Category